Niklas Sandler

• 
  www.pharmj.com/Editorial/20070414/forum/forum_jpag_aps. - [Cached Version]
  Published on: 4/14/2007    Last Visited: 4/14/2007  

  Consideration should be given to the quality attributes of incoming materials, and their processability for each unit operation, in the spirit of the process analytical technology guidelines, said Niklas Sandler, of AstraZeneca.Physical and mechanical attributes of pharmaceutical ingredients have not always necessarily been well understood and consequently the undetected variability of raw materials may be manifested in the final product.
  
  To understand those quality attributes which are critical to product quality, the establishment of effective processes for managing physical attributes of raw and in-process materials is essential.Dr Sandler described the use of quality risk analysis to highlight some possible impacts of the active pharmaceutical ingredient (API) on a roller-compacted product.In this context the influence of API properties on product manufacturability was studied by assessing the flow properties of the formulation during different processing steps.
  ...
  Developing a fundamental knowledge of functional material properties is an essential component in the development of a robust drug product formulation and processing route, concluded Dr Sandler.

• 
  www.pssrc.org/index.php?id=cluster_members&tx_wecstaffd - [Cached Version]
  Published on: 12/10/2008    Last Visited: 12/10/2008  

  Niklas Sandler

• 
  www.controlledrelease.org/meeting/2009/program/EducWork - [Cached Version]
  Published on: 1/1/2009    Last Visited: 10/30/2009  

  Dynamic 3-D Image Analysis in Characterisation of Powder Functionality, Niklas Sandler, University of Helsinki, Finland

• 
  www.americanpharmaceuticalreview.com/ViewArticle.aspx?C - [Cached Version]
  Last Visited: 6/5/2009  

  Dr. Niklas Sandler Senior Researcher, Division of Pharmaceutical Technology University of Helsinki-Finland

• 
  American Pharmaceutical Review - Articles - [Cached Version]
  Last Visited: 9/18/2009  

  Niklas Sandler, Ph.D. University of Otago

• 
  Cluster Members - [Cached Version]
  Published on: 7/7/2009    Last Visited: 7/7/2009  

  Niklas Sandler
  ...
  Niklas Sandler Researcher

• 
  Conference Agenda - [Cached Version]
  Published on: 9/19/2007    Last Visited: 7/3/2009  

  Niklas Sandler, Senior Scientist, AstraZeneca

• 
  Conference Sessions - [Cached Version]
  Published on: 9/19/2007    Last Visited: 7/3/2009  

  Niklas Sandler , Senior Scientist, AstraZeneca

• 
  Niklas Sandler - [Cached Version]
  Published on: 7/7/2009    Last Visited: 7/7/2009  

  Niklas Sandler
  ...
  Professor Niklas Sandler
  ...
  Niklas Sandler (né Laitinen) received his M.Sc. (Pharm.) in 1998 from University of Helsinki, Finland after completing his master's studies at Astra-Hässle R&D in Sweden. He got his Ph.D. in pharmaceutical technology from the University of Helsinki 2003 with the thesis entitled "New perspectives for visual characterization of pharmaceutical solids" under the supervision of Professor Jouko Yliruusi. He then worked as a senior lecturer at the Pharmaceutical Technology Division and in 2005-2006 he took up a postdoctoral position with Thomas Rades, University of Otago, New Zealand, focusing on research regarding various solid-state characterization aspects of solid pharmaceuticals. He became a Docent in Pharmaceutical Technology at the University of Helsinki in 2007. Between 2006 and 2008 he had a senior researcher position at AstraZeneca Pharmaceutical and Analytical R&D in the UK working with the material science and process engineering support related to late stage development of the company's drug portfolio. He took up a temporary position as Professor in Industrial Pharmacy (Anne Juppo's maternity leave cover) at the University of Helsinki in August 2008.
  
  Research interests
  
  Professor Niklas Sandler is currently leading the Industrial Pharmacy research group at the University of Helsinki. The group current projects have concentrate on studies of characteristics and processability enhancement of amorphous systems and investigations on process miniaturization in supporting efficiency of development of solid dosage including enhanced formulation screening.
  
  Niklas Sandler has a wide range of publications in the areas of new image analysis approaches for solid particulates, solid state characterization and data analysis employing multivariate techniques and neural network approaches. He has interest in excipient functionality and is a member of the international steering committee for the Handbook of Pharmaceutical Excipients.
  
  List of publications
  
  Latest publications listed in Google Scholar (Niklas Sandler) (opens in new window)

• 
  Ouluinnovation - Current - [Cached Version]
  Last Visited: 10/31/2009  

  Professor Niklas Sandler, University of Helsinki/Åbo Akademi University, Turku, Finland

Page:  1 2